BMPR2 and pulmonary arterial hypertension: Because AKT activation and signaling have been implicated in PAH pathogenesis through its pro-survival, anti-apoptotic functions [5,6,7], PI3K/AKT was targeted to determine whether its blockade would ameliorate aberrant phenotypic changes associated with BMPR2 loss.